Evidence map›Paper›PMID 39135307›Full record

ReviewBrain and behavior2024

Neuromyelitis optica spectrum disorder: Exploring the diverse clinical manifestations and the need for further exploration.

Hamid Noori, Mohammed Dheyaa Marsool Marsool, Krutika Mahendra Gohil, Muhammad Idrees, Tushar Subash, Zainab Alazzeh, Priyadarshi Prajjwal, Hritvik Jain, Omniat Amir

Abstract readReview
In one paragraph

Review in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Rare association of Tolosa-Hunt Syndrome with Sjogren's Syndrome: case report and review of immunological links across autoimmune disorders".Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hamid NooriNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Mohammed Dheyaa Marsool MarsoolAl-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-3481-4534
Krutika Mahendra GohilHinduhridaysamrat Balasaheb Thackeray Medical College and Dr. Rustom Narsi Cooper Municipal General Hospital, Mumbai, India.ORCID https://orcid.org/0000-0002-0808-4646
Muhammad IdreesLahore General Hospital, Lahore, Punjab, Pakistan.
Tushar SubashMedical College, The Aga Khan University, Karachi, Pakistan.
Zainab AlazzehCollege of Medicine, Jordanian University of Science and Technology, Irbid, Jordan.
Priyadarshi PrajjwalCollege of Medicine, Bharati Vidyapeeth Deemed University, Pune, India.
Hritvik JainAll India Institute of Medical Sciences, Jodhpur, India.
Omniat AmirAlmanhal Academy for Science, Manhal University, Khartoum, Sudan.ORCID https://orcid.org/0000-0002-5021-263X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder characterized by inflammatory assaults on the central nervous system (CNS), particularly on the optic nerves and spinal cord. In recent years, a wider range of clinical manifestations of this complex disease have been observed, emphasizing the importance of gaining a more profound understanding beyond optic neuritis (ON) and transverse myelitis (TM). CURRENT KNOWLEDGE: This study explores the many clinical symptoms of NMOSD, including common and uncommon presentations. Distinctive aspects of ON, TM, and diencephalic/brainstem syndromes are examined, highlighting their unique characteristics in contrast to conditions such as multiple sclerosis. We also discuss extra-CNS involvement, such as unusual signs, including muscle involvement, retinal injury, auditory impairment, and rhinological symptoms. AIMS AND

objectivesOur study intends to highlight the wide range and complexity of NMOSD presentations, emphasizing the significance of identifying unusual symptoms for precise diagnosis and prompt management. The specific processes that contribute to the varied clinical presentation of NMOSD are not well understood despite existing information. This emphasizes the necessity for more study to clarify the mechanisms that cause different symptoms and discover new treatment targets for this complex autoimmune disorder.

conclusionIt is essential to acknowledge the complex and varied clinical manifestations of NMOSD to enhance diagnosis, treatment, and patient results. By enhancing our comprehension of the fundamental processes and investigating innovative therapeutic approaches, we may aim to enhance the quality of life for persons impacted by this illness.

Indexed as

Neuromyelitis OpticaHumansautoimmuneclinical featuresneuromyelitis opticaneuromyelitis optica spectrum disordersoptic neuritistransverse myelitis

Identifiers

PMID39135307
PMCPMC11319236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.